Literature DB >> 26112762

Repurposing of rutin for the inhibition of norovirus replication.

Nicolas Chéron1, Chenchen Yu, Abimbola O Kolawole, Eugene I Shakhnovich, Christiane E Wobus.   

Abstract

Drug repurposing is a strategy employed to circumvent some of the bottlenecks involved in drug development, such as the cost and time needed for developing new molecular entities. Noroviruses cause recurrent epidemics and sporadic outbreaks of gastroenteritis associated with significant mortality and economic costs, but no treatment has been approved to date. Herein, a library of molecules previously used in humans was screened to find compounds with anti-noroviral activity. Antiviral testing for four selected compounds against murine norovirus infection revealed that rutin has anti-murine norovirus activity in cell-based assays.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26112762     DOI: 10.1007/s00705-015-2495-y

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

Review 1.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

2.  Quantitative analysis of rutin, quercetin, naringenin, and gallic acid by validated RP- and NP-HPTLC methods for quality control of anti-HBV active extract of Guiera senegalensis.

Authors:  Perwez Alam; Mohammad K Parvez; Ahmed H Arbab; Mohammed S Al-Dosari
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 3.  Repurposing approved drugs on the pathway to novel therapies.

Authors:  Catherine H Schein
Journal:  Med Res Rev       Date:  2019-08-20       Impact factor: 12.944

4.  Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2.

Authors:  Léna Petit; Léa Vernès; Jean-Paul Cadoret
Journal:  J Appl Phycol       Date:  2021-03-20       Impact factor: 3.215

Review 5.  A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease.

Authors:  Alessandra S Rieder; Bruna F Deniz; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Neurotox Res       Date:  2022-08-02       Impact factor: 3.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.